Table 2.
Parameter | Value (N = 1,506) |
---|---|
Chemotherapies, % | |
Epirubicin | 44 |
Cyclophosphamide | 37 |
Paclitaxel | 32 |
Docetaxel | 26 |
Carboplatin | 8 |
Fluorouracil | 8 |
Doxorubicin | 7 |
nab-Paclitaxel | 3 |
Liposomal doxorubicin | 1 |
No data | 8 |
No chemotherapy | 26 |
Antihormonal drugs, % | |
Tamoxifen | 80 |
Aromatase inhibitor | 32 |
Aromatase inhibitor and tamoxifen | 12 |
GnRH analogs | 5 |
Antibodies, % | |
Trastuzumab | 18 |
Pertuzumab | 1 |
Others, % | |
Trastuzumab-emtasine | 0.2 |
Lapatinib | 1 |
GnRH, gonatropin-releasing hormone.